Clinical Trial Update: Silexan in the Treatment Of Posttraumatic Stress Disorder Trial [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Silexan for post-traumatic stress disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• Silexan (Lavandula angustifolia essential oil (Silexan))

Snippet

Sponsor: Deakin University | Conditions: Post Traumatic Stress Disorder | Phase 3 | Status: RECRUITING